Augmentin '125' and Rocuronium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Rocuronium bromide (rocuronium bromide). Common drug interactions include stevens-johnson syndrome among females and oxygen saturation decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Rocuronium bromide. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Rocuronium bromide?

Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.



On Jul, 25, 2026

29 people who take Augmentin '125' and Rocuronium bromide together, and have interactions are studied.

Augmentin '125' and Rocuronium bromide drug interactions.

What are the common drug interactions of Augmentin '125' and Rocuronium Bromide, by gender? *:

female:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Anuria (failure of the kidneys to produce urine)
  3. Pleural effusion (water on the lungs)
  4. Septic shock (shock due to blood infection)
  5. Toxic skin eruption (skin breakdown due to toxic substance)
  6. Acute respiratory distress syndrome
  7. Anaphylactic reaction (serious allergic reaction)
  8. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  9. Hypotension (abnormally low blood pressure)
  10. Respiratory distress (difficulty in breathing)

male:

  1. Oxygen saturation decreased
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Pulseless electrical activity
  4. Rash
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Cardiac arrest
  7. Hypotension (abnormally low blood pressure)
  8. Respiratory disorder (respiratory disease)
  9. Ventricular fibrillation (abnormally irregular heart rhythm)
  10. Anaphylactic reaction (serious allergic reaction)

What are the common drug interactions of Augmentin '125' and Rocuronium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Hypercapnia (too much smoke)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)
  6. Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
  7. Oxygen saturation decreased
  8. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  9. Pulseless electrical activity
  10. Rash

30-39:

n/a

40-49:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Anuria (failure of the kidneys to produce urine)
  3. Pleural effusion (water on the lungs)
  4. Septic shock (shock due to blood infection)
  5. Toxic skin eruption (skin breakdown due to toxic substance)
  6. Acute respiratory distress syndrome
  7. Respiratory distress (difficulty in breathing)
  8. Asthma
  9. Hypersensitivity
  10. Joint swelling

50-59:

  1. Hypotension (abnormally low blood pressure)
  2. Oxygen saturation decreased
  3. Respiratory disorder (respiratory disease)
  4. Ventricular fibrillation (abnormally irregular heart rhythm)
  5. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  6. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  7. Cardiac arrest

60+:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  3. Hypotension (abnormally low blood pressure)
  4. Blood pressure decreased
  5. Cardiac arrest
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Erythema (redness of the skin)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 2 people, 6.90%
  2. Gout (uric acid crystals building up in the body): 2 people, 6.90%
  3. Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 2 people, 6.90%
  4. Bacteroides Infection (infection of bacteroides-a genus of gram-negative, bacillus bacteria): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Rocuronium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin '125' and Rocuronium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rocuronium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rocuronium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and rocuronium bromide (the active ingredients of Augmentin '125' and Rocuronium bromide, respectively), and Augmentin '125' and Rocuronium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: